SBRA - Nucor Sabra Health Care And A Major Investment Bank: CNBC's 'Final Trades' | Benzinga
On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management said Sabra Health Care REIT, Inc. (NASDAQ: SBRA) has a 9% yield and 5% earnings growth.
Deutsche Bank analyst Omotayo Okusanya initiated coverage on Sabra Health Care REIT with a Buy rating and announced a price target of $21. Sabra Health Care recently named Jessica Flores as executive vice president and chief accounting officer.
Josh Brown of Ritholtz Wealth Management picked The Goldman Sachs ...